Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/140652 |
Resumo: | Mechanisms of malaria parasite interaction with its host red blood cell may provide potential targets for new antimalarial approaches. Pyruvate kinase deficiency has been associated with resistance to malaria in both experimental models and population studies. Two of the major pyruvate kinase deficient-cell disorders are the decrease in ATP and the increase in 2,3-biphosphoglycerate (2,3-BPG) concentration. High levels of this metabolite, only present in mammalian red blood cell, has an inhibitory effect on glycolysis and we hypothesized that its accumulation may also be harmful to the parasite and be involved in the mechanism of protection provided by that enzymopathy. We examined the effect of a synthetic form, 2,3-DPG, on the Plasmodium falciparum intraerythrocytic developmental cycle in vitro. Results showed an impairment of parasite growth with a direct effect on parasite maturation as significant lower progeny emerged from parasites that were submitted to 2,3-DPG. Further, adding the compound to the culture medium did not result in any effect on the host cell, but instead the metabolic profile of an infected cell became closer to that of a non-infected cell. |
id |
RCAP_75efffbe35274599e047d6abafcd056f |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/140652 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In VitroMalariaHost-parasite interactionsRed blood cell2,3-DPGGlycolysisPyruvate kinase deficiency2,3-BPGBiochemistry, Genetics and Molecular Biology (miscellaneous)Applied Microbiology and BiotechnologyParasitologyBiochemistry, medicalEpidemiologyPharmacology, Toxicology and Pharmaceutics (miscellaneous)SDG 1 - No PovertySDG 3 - Good Health and Well-beingSDG 9 - Industry, Innovation, and InfrastructureSDG 10 - Reduced InequalitiesMechanisms of malaria parasite interaction with its host red blood cell may provide potential targets for new antimalarial approaches. Pyruvate kinase deficiency has been associated with resistance to malaria in both experimental models and population studies. Two of the major pyruvate kinase deficient-cell disorders are the decrease in ATP and the increase in 2,3-biphosphoglycerate (2,3-BPG) concentration. High levels of this metabolite, only present in mammalian red blood cell, has an inhibitory effect on glycolysis and we hypothesized that its accumulation may also be harmful to the parasite and be involved in the mechanism of protection provided by that enzymopathy. We examined the effect of a synthetic form, 2,3-DPG, on the Plasmodium falciparum intraerythrocytic developmental cycle in vitro. Results showed an impairment of parasite growth with a direct effect on parasite maturation as significant lower progeny emerged from parasites that were submitted to 2,3-DPG. Further, adding the compound to the culture medium did not result in any effect on the host cell, but instead the metabolic profile of an infected cell became closer to that of a non-infected cell.Vector borne diseases and pathogens (VBD)Global Health and Tropical Medicine (GHTM)Instituto de Higiene e Medicina Tropical (IHMT)Centro de Estudos de Doenças Crónicas (CEDOC)NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNMorais, InesMedeiros, M.M.Carvalho, MariaMorello Bullon, JuditM. Teixeira, SaraMaciel, SuelmaNhantumbo, JaniceBalau, AnaT.G. Rosa, MargaridaNogueira, FA. Rodrigues, JoãoCarvalho, Filomena A.Antunes, Alexandra M MArez, Ana Paula2022-06-23T22:24:09Z2022-03-152022-03-15T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article14application/pdfhttp://hdl.handle.net/10362/140652eng2235-2988PURE: 42494547https://doi.org/10.3389/fcimb.2022.840968info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:17:50Zoai:run.unl.pt:10362/140652Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:49:45.009309Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro |
title |
Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro |
spellingShingle |
Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro Morais, Ines Malaria Host-parasite interactions Red blood cell 2,3-DPG Glycolysis Pyruvate kinase deficiency 2,3-BPG Biochemistry, Genetics and Molecular Biology (miscellaneous) Applied Microbiology and Biotechnology Parasitology Biochemistry, medical Epidemiology Pharmacology, Toxicology and Pharmaceutics (miscellaneous) SDG 1 - No Poverty SDG 3 - Good Health and Well-being SDG 9 - Industry, Innovation, and Infrastructure SDG 10 - Reduced Inequalities |
title_short |
Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro |
title_full |
Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro |
title_fullStr |
Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro |
title_full_unstemmed |
Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro |
title_sort |
Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro |
author |
Morais, Ines |
author_facet |
Morais, Ines Medeiros, M.M. Carvalho, Maria Morello Bullon, Judit M. Teixeira, Sara Maciel, Suelma Nhantumbo, Janice Balau, Ana T.G. Rosa, Margarida Nogueira, F A. Rodrigues, João Carvalho, Filomena A. Antunes, Alexandra M M Arez, Ana Paula |
author_role |
author |
author2 |
Medeiros, M.M. Carvalho, Maria Morello Bullon, Judit M. Teixeira, Sara Maciel, Suelma Nhantumbo, Janice Balau, Ana T.G. Rosa, Margarida Nogueira, F A. Rodrigues, João Carvalho, Filomena A. Antunes, Alexandra M M Arez, Ana Paula |
author2_role |
author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Vector borne diseases and pathogens (VBD) Global Health and Tropical Medicine (GHTM) Instituto de Higiene e Medicina Tropical (IHMT) Centro de Estudos de Doenças Crónicas (CEDOC) NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Morais, Ines Medeiros, M.M. Carvalho, Maria Morello Bullon, Judit M. Teixeira, Sara Maciel, Suelma Nhantumbo, Janice Balau, Ana T.G. Rosa, Margarida Nogueira, F A. Rodrigues, João Carvalho, Filomena A. Antunes, Alexandra M M Arez, Ana Paula |
dc.subject.por.fl_str_mv |
Malaria Host-parasite interactions Red blood cell 2,3-DPG Glycolysis Pyruvate kinase deficiency 2,3-BPG Biochemistry, Genetics and Molecular Biology (miscellaneous) Applied Microbiology and Biotechnology Parasitology Biochemistry, medical Epidemiology Pharmacology, Toxicology and Pharmaceutics (miscellaneous) SDG 1 - No Poverty SDG 3 - Good Health and Well-being SDG 9 - Industry, Innovation, and Infrastructure SDG 10 - Reduced Inequalities |
topic |
Malaria Host-parasite interactions Red blood cell 2,3-DPG Glycolysis Pyruvate kinase deficiency 2,3-BPG Biochemistry, Genetics and Molecular Biology (miscellaneous) Applied Microbiology and Biotechnology Parasitology Biochemistry, medical Epidemiology Pharmacology, Toxicology and Pharmaceutics (miscellaneous) SDG 1 - No Poverty SDG 3 - Good Health and Well-being SDG 9 - Industry, Innovation, and Infrastructure SDG 10 - Reduced Inequalities |
description |
Mechanisms of malaria parasite interaction with its host red blood cell may provide potential targets for new antimalarial approaches. Pyruvate kinase deficiency has been associated with resistance to malaria in both experimental models and population studies. Two of the major pyruvate kinase deficient-cell disorders are the decrease in ATP and the increase in 2,3-biphosphoglycerate (2,3-BPG) concentration. High levels of this metabolite, only present in mammalian red blood cell, has an inhibitory effect on glycolysis and we hypothesized that its accumulation may also be harmful to the parasite and be involved in the mechanism of protection provided by that enzymopathy. We examined the effect of a synthetic form, 2,3-DPG, on the Plasmodium falciparum intraerythrocytic developmental cycle in vitro. Results showed an impairment of parasite growth with a direct effect on parasite maturation as significant lower progeny emerged from parasites that were submitted to 2,3-DPG. Further, adding the compound to the culture medium did not result in any effect on the host cell, but instead the metabolic profile of an infected cell became closer to that of a non-infected cell. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-06-23T22:24:09Z 2022-03-15 2022-03-15T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/140652 |
url |
http://hdl.handle.net/10362/140652 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2235-2988 PURE: 42494547 https://doi.org/10.3389/fcimb.2022.840968 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
14 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138095765913600 |